A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of three doses of topiramate
(50 milligrams[mg], 100mg, and 200mg taken daily) compared with placebo in the prevention of
migraine.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.